ARCHIVES

NCI CTEP-Approved Trials For the Month of March

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity.

July 12, 2002

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

50-Gene Set Identifies Known Types Of Breast Cancer

February 27, 2009

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

February 14, 2014

Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49

April 4, 1997